Your browser doesn't support javascript.
loading
Brentuximab vedotin for refractory anaplastic lymphoma kinase-negative anaplastic large cell lymphoma in leukemic phase with RUNX3 overexpression.
Yamashita, Yusuke; Hori, Yoshikazu; Kosako, Hideki; Oiwa, Takehiro; Warigaya, Kenji; Mushino, Toshiki; Murata, Shogo; Fujimoto, Masakazu; Nishikawa, Akinori; Murata, Shin-Ichi; Sonoki, Takashi; Tamura, Shinobu.
Afiliación
  • Yamashita Y; Department of Hematology/Oncology.
  • Hori Y; Department of Hematology/Oncology.
  • Kosako H; Department of Hematology/Oncology.
  • Oiwa T; Department of Hematology/Oncology.
  • Warigaya K; Department of Diagnostic Pathology, Wakayama Medical University, Wakayama, Japan.
  • Mushino T; Department of Hematology/Oncology.
  • Murata S; Department of Hematology/Oncology.
  • Fujimoto M; Department of Diagnostic Pathology, Wakayama Medical University, Wakayama, Japan.
  • Nishikawa A; Department of Hematology/Oncology.
  • Murata SI; Department of Diagnostic Pathology, Wakayama Medical University, Wakayama, Japan.
  • Sonoki T; Department of Hematology/Oncology.
  • Tamura S; Department of Hematology/Oncology.
Hematol Rep ; 12(1): 8368, 2020 May 06.
Article en En | MEDLINE | ID: mdl-32499905
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Hematol Rep Año: 2020 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Hematol Rep Año: 2020 Tipo del documento: Article